Pfizer-Seagen: Dividend Risk Evaluation


  • Does the rumored Seagen Inc. deal jeopardize Pfizer Inc.’s ability to pay dividends to shareholders?
  • Despite COVID reset, fundamental numbers look strong.
  • However, while I like Pfizer as a company, I acknowledge it is not my typical dividend growth stock.

Pfizer Canada head office in Kirkland, Quebec, Canada.


Pfizer Inc. (NYSE:PFE) is reportedly in early negotiations to acquire cancer-focused biotech Seagen Inc. (SGEN) as Seeking Alpha has reported here. As part dividend growth investor and a long-term follower of Pfizer, I remember when the

Pfizer FCF

Pfizer FCF (

Disclosure: I/we have a beneficial long position in the shares of PFE either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Leave a Reply

Your email address will not be published. Required fields are marked *